179 related articles for article (PubMed ID: 11699134)
1. A dose of reality for the health watchdogs.
Kluger J
Time; 2001 Oct; 158(19):65-6. PubMed ID: 11699134
[No Abstract] [Full Text] [Related]
2. Teleconferences help educate on bioterrorism.
Hosp Peer Rev; 2002 Apr; 27(4):55-7. PubMed ID: 11951725
[No Abstract] [Full Text] [Related]
3. Bioterrorism: a clear and present danger.
Lane HC; Montagne JL; Fauci AS
Nat Med; 2001 Dec; 7(12):1271-3. PubMed ID: 11726956
[No Abstract] [Full Text] [Related]
4. Our first line of defense against bioterrorism part 2.
Simpson RL
Nurs Manage; 2002 May; 33(5):10, 11. PubMed ID: 12006878
[TBL] [Abstract][Full Text] [Related]
5. Bioterrorism watch. Building a bridge over the abyss: will bioterrorism help bring disjointed health system together?
Evans G
Hosp Peer Rev; 2002 Apr; 27(4):suppl 1-2. PubMed ID: 11951727
[No Abstract] [Full Text] [Related]
6. Responding to anthrax.
Borg MA; Tieck WC
J Dent Technol; 2001; 18(8):12-4, 28. PubMed ID: 11885187
[No Abstract] [Full Text] [Related]
7. Anthrax bioterrorism: lessons learned and future directions.
Hughes JM; Gerberding JL
Emerg Infect Dis; 2002 Oct; 8(10):1013-4. PubMed ID: 12396907
[No Abstract] [Full Text] [Related]
8. Lessons learned from the CDC's post-exposure prophylaxis program following the anthrax attacks of 2001.
Bresnitz EA
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):389-91. PubMed ID: 15924332
[No Abstract] [Full Text] [Related]
9. Smallpox vaccine: the reality, the risk.
Taccetta-Chapnick M
RN; 2003 Jul; 66(7):52-8; quiz 60. PubMed ID: 12900999
[No Abstract] [Full Text] [Related]
10. Biodefense. House passes plan for drug, vaccine R&D.
Kaiser J
Science; 2006 Oct; 314(5796):39. PubMed ID: 17023625
[No Abstract] [Full Text] [Related]
11. Bioterrorism. BioShield is slow to build U.S. defenses against bioweapons.
Kaiser J
Science; 2006 Jul; 313(5783):28-9. PubMed ID: 16825542
[No Abstract] [Full Text] [Related]
12. Biodefense. Critics question proposed countermeasures agency.
Kaiser J
Science; 2005 Nov; 310(5749):755. PubMed ID: 16272086
[No Abstract] [Full Text] [Related]
13. Project Bioshield: protecting Americans from terrorism.
Meadows M
FDA Consum; 2004; 38(6):32-3. PubMed ID: 15675025
[No Abstract] [Full Text] [Related]
14. Ethics and bioterrorism research.
Bull Med Ethics; 2004 May; (198):13-20. PubMed ID: 15832477
[No Abstract] [Full Text] [Related]
15. Throwing money at biodefense.
DeFrancesco L
Nat Biotechnol; 2004 Apr; 22(4):375-8. PubMed ID: 15060542
[No Abstract] [Full Text] [Related]
16. Agency set up to tackle bioterror.
Wadman M
Nature; 2006 Dec; 444(7121):796-7. PubMed ID: 17167438
[No Abstract] [Full Text] [Related]
17. Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.
Kesselheim AS
Clin Pharmacol Ther; 2009 Jun; 85(6):573-5. PubMed ID: 19451908
[No Abstract] [Full Text] [Related]
18. US biodefense contracts continue to lure biotechs.
Shaffer C
Nat Biotechnol; 2010 Mar; 28(3):187-8. PubMed ID: 20212465
[No Abstract] [Full Text] [Related]
19. Bioterrorism today.
Snell N
Biologist (London); 2002 Jun; 49(3):140. PubMed ID: 12097718
[TBL] [Abstract][Full Text] [Related]
20. Staying healthy. A public mess.
Kluger J
Time; 2002 Jan; 159(3):92-4, 97. PubMed ID: 11833132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
